Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01083459 · ClinicalTrials.gov registry record
Impact of PCV on Disease and Colonization Among Native American Communities
A clinical trial, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- 6,628
- Enrollment target
NCT01083459: Completed study, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT01083459 is a clinical trial that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 6,628 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01083459 has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- 6,628 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the impact of pneumococcal conjugate vaccine on carriage of pneumococcus in the nasopharynx and on the incidence of invasive pneumococcal disease in the community.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,628 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-04 |
What the finished NCT01083459 record still lists
NCT01083459 is an observational study that tracks outcomes without assigning an intervention. Its 6,628 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01083459 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01083459 about?
NCT01083459 is a clinical study titled "Impact of PCV on Disease and Colonization Among Native American Communities". The purpose of this study is to determine the impact of pneumococcal conjugate vaccine on carriage of pneumococcus in the nasopharynx and on the incidence of invasive pneumococcal disease in the community.
What is the current status of trial NCT01083459?
This trial is currently completed. The enrollment target is 6,628 participants. The study started on 2010-01. Estimated completion is 2012-04.
Who is sponsoring clinical trial NCT01083459?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06272045 · 6,618 participants · NA
Early Intervention to Promote Cardiovascular Health of Mothers and Children
- NCT05143697 · 6,600 participants · NA
Motivational Wellness Coaching to Reduce Childhood Obesity in Families and Kids
- NCT05515224 · 6,600 participants · NA
5-Cog 2.0: A Pragmatic Clinical Trial
- NCT05121324 · 6,700 participants · Phase 3
Pediatric Dose Optimization for Seizures in Emergency Medical Services
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia